Purple Biotech
PPBT
8 hedge funds and large institutions have $651K invested in Purple Biotech in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
38% less capital invested
Capital invested by funds: $1.04M → $651K (-$392K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$175K |
| 2 |
MC
Menta Capital
San Francisco,
California
|
+$143K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$24.9K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$24.9K |
| 5 |
FMA
FNY Managed Accounts
New York
|
+$18.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$725K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$80K |
| 3 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$46K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MC
1
Menta Capital
San Francisco,
California
| $214K | +$143K | +23 | +288% |
|
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $195K | +$175K | +28 | New |
|
|
VKH
3
Virtu KCG Holdings
New York
| $115K | +$12.5K | +2 | +13% |
|
4
Jane Street
New York
| $49K | +$6.24K | +1 | +17% |
|
|
5
Creative Planning
Overland Park,
Kansas
| $27K | +$24.9K | +4 | New |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $26K | +$24.9K | +4 | New |
|
|
FMA
7
FNY Managed Accounts
New York
| $17.4K | +$18.7K | +3 | New |
|
8
Wells Fargo
San Francisco,
California
| $7K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1K | – | – | – |
|
|
SM
10
Sabby Management
Miami Beach,
Florida
| – | -$725K | -116 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$80K | -13 | Closed |
|
|
FAAS
12
First Allied Advisory Services
San Diego,
California
| – | -$46K | -8 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$8K | -1 | Closed |
|
PPBT Hedge Fund Activity: Q3 2016 in Review
8 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q3 2016, worth a combined $651K — down 38% from $1.04M a quarter earlier.
Fund positioning in PPBT was balanced in Q3 2016: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $175K. The largest seller was Sabby Management, exiting entirely with an estimated $725K sold.
- 8 institutional investors held Purple Biotech (PPBT) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $651K of Purple Biotech stock for Q3 2016, down 38% quarter-over-quarter.
- 4 funds opened new Purple Biotech positions in Q3 2016 and 4 closed out, a net change of 0 holders.
- The largest Purple Biotech buyer in Q3 2016 was Deutsche Bank, an estimated $175K added.
- The largest Purple Biotech seller in Q3 2016 was Sabby Management, an estimated $725K sold.
Based on aggregated 13F filings for Q3 2016.